Porter's Five Forces Analysis: Pharmacies in New Farm, QLD (2026)
Strategique's Porter's Five Forces draws on live competitor intelligence and ABS demographic data for New Farm, QLD. Use this analysis as a starting point — then run your free Strategique Score to see the full competitive landscape.
The takeaway
New Farm is a high-income, low-density opportunity with moderate rivalry and strong buyer power — enter as a premium advisory pharmacy, not a discount script mill. Lock in review dominance within 90 days, secure premium retail supplier agreements immediately, and differentiate on health services and convenience (not price) to capture the 47% income premium this market offers. Move within 12 months before a second well-capitalized competitor identifies the same gap.
Considering opening here?
Pharmacy registration barriers are high (accreditation, pharmacist requirement), but capital and lease costs in New Farm are moderate relative to Brisbane CBD; a second well-funded competitor could enter within 18–24 months. Act now: Secure the best foot-traffic corner lease (within 500m of New Farm precinct hub) and build brand equity through 12-month community health partnerships (free blood pressure screening, workplace wellness talks at local businesses) before a corporate chain identifies this as a high-income fill opportunity. Once TerryWhite or a major banner locks in a second strong location, your margin shrinks.
Already operating here?
Three operators in a 12,454-person SA2 means low density (Moderate-tier), but TerryWhite's 4.8★ rating on 103 reviews signals entrenched market leadership and review-dominance vulnerability for new entrants. Counter-move: Launch with a targeted 90-day review acquisition sprint (target 40+ reviews in first quarter) to prevent TerryWhite from becoming the default choice in Google/Google Maps — this segment is health-conscious and searches pharmacy reviews before visits. Ramsay's dual presence (3.8★ and 2.8★) shows inconsistent execution; exploit this by locking in consistent customer experience and service repeatability across all touchpoints.
Five Forces Assessment
| Force | Intensity | Rationale |
|---|---|---|
| Competitive Rivalry | Moderate | Three operators in a 12,454-person SA2 means low density (Moderate-tier), but TerryWhite's 4.8★ rating on 103 reviews signals entrenched market leadership and review-dominance vulnerability for new entrants. Counter-move: Launch with a targeted 90-day review acquisition sprint (target 40+ reviews in first quarter) to prevent TerryWhite from becoming the default choice in Google/Google Maps — this segment is health-conscious and searches pharmacy reviews before visits. Ramsay's dual presence (3.8★ and 2.8★) shows inconsistent execution; exploit this by locking in consistent customer experience and service repeatability across all touchpoints. |
| Supplier Power | Low | PBS supply chains are national and standardized; no local supplier lockout exists. However, premium retail suppliers (skincare, vitamins, wellness) have selective distribution — lock in preferred distributor agreements for premium front-of-shop lines (e.g., TGA-approved skincare, nutraceuticals) within 60 days of opening. Product unavailability in a high-income market bleeds customers faster than price; this cohort will cross postcodes for brands, but not for empty shelves. Secure 90-day minimum stock commitments upfront. |
| Buyer Power | High | $2,069 median weekly household income (47% above national median) and 4.26% unemployment mean customers have choice and money. They will not trade down on convenience, service quality, or health advice — they will trade pharmacies. Set pricing 5–8% above discount chains on OTC wellness and private-label items (not PBS); this cohort views lower price as signal of lower quality on preventive health products. Compete on advisory services (pharmacist-led wellness consultations, skincare matching, preventive health screening) and convenience (extended hours, online ordering, home delivery) rather than price. Buyers here have low price sensitivity on non-PBS items and high sensitivity to service gaps. |
| Threat of New Entrants | Moderate | Pharmacy registration barriers are high (accreditation, pharmacist requirement), but capital and lease costs in New Farm are moderate relative to Brisbane CBD; a second well-funded competitor could enter within 18–24 months. Act now: Secure the best foot-traffic corner lease (within 500m of New Farm precinct hub) and build brand equity through 12-month community health partnerships (free blood pressure screening, workplace wellness talks at local businesses) before a corporate chain identifies this as a high-income fill opportunity. Once TerryWhite or a major banner locks in a second strong location, your margin shrinks. |
| Threat of Substitutes | Moderate | Online pharmacies (e.g., Chemist Warehouse, Amazon Pharmacy) and telehealth (e.g., Eucalyptus, Plushcare) are eroding PBS script volume nationally, but New Farm's affluent, health-conscious base values face-to-face advisory and immediate product access. Differentiation move: Position as the 'preventive health hub' — layer in services competitors don't: pharmacist consultations on drug interactions (free, 15-min slots), personalized supplement recommendations, flu/COVID vaccination clinics, and minor ailment triage. This is defensible against online and telehealth because it requires physical presence and clinical judgment — your profit pool shifts from volume scripts to margin-rich services and premium retail. Don't compete on script price; compete on preventing the need for scripts. |
New Farm is a high-income, low-density opportunity with moderate rivalry and strong buyer power — enter as a premium advisory pharmacy, not a discount script mill. Lock in review dominance within 90 days, secure premium retail supplier agreements immediately, and differentiate on health services and convenience (not price) to capture the 47% income premium this market offers. Move within 12 months before a second well-capitalized competitor identifies the same gap.
Frequently Asked Questions
Should I compete on script price to undercut TerryWhite or Ramsay?
No. PBS margins are capped and TerryWhite's 4.8★ rating means they own price-script volume in this segment. Your margin lives in OTC wellness, skincare, and private-label supplements — price 5–8% above discount chains and justify it with pharmacist consultations. This cohort pays premium for quality advice, not for $2 script discounts.
What's the biggest risk to entering New Farm right now?
Review-space capture by TerryWhite (103 reviews, 4.8★) before you launch. If you enter without a rapid review acquisition strategy, Google/Maps will route 70%+ of search traffic to them for 18 months. Launch with a 90-day sprint: free loyalty card first 100 customers, follow-up SMS asking for reviews, partner with local health/wellness businesses to cross-refer. This is your fastest path to market visibility.
How do I position against telehealth and online pharmacies eating PBS volume?
Stop competing on scripts. Launch as a 'Preventive Health Hub': offer pharmacist-led blood pressure/cholesterol screening (free, weekly), workplace wellness talks (partner with local corporate offices), minor ailment consultations, and supplement matching based on health data. Bundle OTC premium skincare and nutraceuticals into 'health packages' — this segment has money and values convenience + advice over price. Telehealth can't do this; online can't deliver the trust or personalization. Your moat is clinical judgment + immediate product access.
Your next step: See demand and capacity benchmarks
The Strategique Score combines competitor density, market opportunity and demographic fit into a single 0–100 rating — free, no signup needed.
See demand and capacity benchmarks →